Literature DB >> 11778697

Characterization of ATI, TK and IFN-alpha/betaR genes in the genome of the BeAn 58058 virus, a naturally attenuated wild Orthopoxvirus.

J T Marques1, G D Trindade, F G Da Fonseca, J R Dos Santos, C A Bonjardim, P C Ferreira, E G Kroon.   

Abstract

The lack of knowledge about the natural host of Vaccinia virus (VV) along with the description of human infections caused by poxviruses after smallpox eradication has increased the need to characterize poxviruses isolated from the wild. Moreover, in the past years poxviruses have been widely studied as potential vaccination tools, with the discovery of several genes implicated in the evasion of the host immune response involved in virus pathogenesis. Among them, an Interferon (IFN)-binding protein was identified in the supernatant of VV strain WR infected cells coded by the B18R gene. It was shown that many other Orthopoxviruses also encode and express this soluble receptor although some VV strains such as Lister and modified Ankara, which were less reactogenic vaccines, do not. The BeAn 58058 virus (BAV) has been recently characterized and proposed to be an Orthopoxvirus. BAV was also shown to be less virulent in animal models than VV Lister. Here we report the identification of an IFN-alpha/betaR gene in the BAV genome with 99% of sequence identity with the VVWR B18R gene. The identified gene encodes a B18R-like IFN binding protein as demonstrated by its capacity to inhibit the IFN-mediated protection of VERO cells against EMC virus. In order to better characterize the virus we have searched for the A type inclusion body (ATI) gene currently used in the classification of Orthopoxviruses but did not detect it in the BAV genome. We have also sequenced the BAV thymidine kinase (TK) gene, a poxvirus-conserved gene, which, as expected, showed high homology with the TK gene of other poxviruses. Phylogenetic trees were constructed based on sequences of the IFN-alpha/betaR and TK genes from several poxviruses and in both cases BAV was placed in the same cluster as other VV strains. These observations strengthened the hypothesis that this virus is a variant of the VV vaccine used in Brazil. However the explanation for the BAV lack of virulence remains to be discovered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778697     DOI: 10.1023/a:1012521322845

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  35 in total

1.  The purification fo four strains of poxvirus.

Authors:  W K JOKLIK
Journal:  Virology       Date:  1962-09       Impact factor: 3.616

2.  Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.

Authors:  I Ourmanov; C R Brown; B Moss; M Carroll; L Wyatt; L Pletneva; S Goldstein; D Venzon; V M Hirsch
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Ecology of orthopoxviruses and use of recombinant vaccinia vaccines.

Authors:  D Baxby; R M Gaskell; C J Gaskell; M Bennett
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321

4.  Studies on Cotia virus--an unclassified poxvirus.

Authors:  Y Ueda; K R Dumbell; T Tsuruhara; I Tagaya
Journal:  J Gen Virol       Date:  1978-08       Impact factor: 3.891

5.  Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Authors:  B S Bender; C A Rowe; S F Taylor; L S Wyatt; B Moss; P A Small
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

6.  The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein.

Authors:  C G Miller; S N Shchelkunov; G J Kotwal
Journal:  Virology       Date:  1997-03-03       Impact factor: 3.616

7.  Studies on the poxvirus Cotia.

Authors:  J J Esposito; E L Palmer; E C Borden; A K Harrison; J F Obijeski; F A Murphy
Journal:  J Gen Virol       Date:  1980-03       Impact factor: 3.891

Review 8.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

9.  Orthopoxvirus DNA: a comparison of restriction profiles and maps.

Authors:  J J Esposito; J C Knight
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

10.  Gene for A-type inclusion body protein is useful for a polymerase chain reaction assay to differentiate orthopoxviruses.

Authors:  H Meyer; S L Ropp; J J Esposito
Journal:  J Virol Methods       Date:  1997-03       Impact factor: 2.623

View more
  11 in total

1.  The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.

Authors:  Anderson A Andrade; Patrícia N G Silva; Anna C T C Pereira; Lirlândia P De Sousa; Paulo C P Ferreira; Ricardo T Gazzinelli; Erna G Kroon; Catherine Ropert; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

2.  Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.

Authors:  Giliane de Souza Trindade; Flávio Guimarães da Fonseca; João Trindade Marques; Maurício Lacerda Nogueira; Luiz Claudio Nogueira Mendes; Alexandre Secorun Borges; Juliana Regina Peiró; Edviges Maristela Pituco; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

3.  Emergence and reemergence of vaccinia-like viruses: global scenario and perspectives.

Authors:  R K Singh; V Balamurugan; V Bhanuprakash; G Venkatesan; M Hosamani
Journal:  Indian J Virol       Date:  2012-04-04

4.  Epidemic of unilateral panuveitis in children from Brazilian Amazonia: clinical and etiological aspects in seven patients.

Authors:  Daniel Vítor Vasconcelos-Santos; Fernando Oréfice; Carlos Franklin Fonseca; Leandro Moulin Alencar; Priscilla Jane Ayres Almeida; Henrique Leonel Lenzi; Marcelo Pelajo-Machado; Cecília Volkmer-Ribeiro; Twiggy Cristina Alves Batista; Pedro Paulo Chieffi; Susana Zevallos Lescano; Roberta Lima Caldeira; Omar Dos Santos Carvalho; Carlos Eduardo Pavesio
Journal:  Int Ophthalmol       Date:  2009-01-23       Impact factor: 2.031

5.  Brazilian Vaccinia virus strains show genetic polymorphism at the ati gene.

Authors:  Juliana Almeida Leite; Betânia Paiva Drumond; Giliane de Souza Trindade; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Virus Genes       Date:  2007-08-02       Impact factor: 2.198

Review 6.  Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly.

Authors:  Jaqueline Silva de Oliveira; Poliana de Oliveira Figueiredo; Galileu Barbosa Costa; Felipe Lopes de Assis; Betânia Paiva Drumond; Flávio Guimarães da Fonseca; Maurício Lacerda Nogueira; Erna Geessien Kroon; Giliane de Souza Trindade
Journal:  Viruses       Date:  2017-11-15       Impact factor: 5.048

7.  Complete Genome Sequence of the BeAn 58058 Virus Isolated from Oryzomys sp. Rodents in the Amazon Region of Brazil.

Authors:  A L M Wanzeller; A L P Souza; R S S Azevedo; E C Sousa Júnior; L C F Filho; R S Oliveira; P S Lemos; J V Júnior; P F C Vasconcelos
Journal:  Genome Announc       Date:  2017-03-02

8.  Brazilian vaccinia viruses and their origins.

Authors:  Giliane S Trindade; Ginny L Emerson; Darin S Carroll; Erna G Kroon; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Dairy production practices and associated risks for bovine vaccinia exposure in cattle, Brazil.

Authors:  I A Borges; A M McCollum; J M Mehal; D Haberling; L A L Dutra; F N Vieira; L A O Andrade; E G Kroon; R C Holman; M G Reynolds; G S Trindade
Journal:  New Microbes New Infect       Date:  2017-08-16

10.  Seroprevalence and Risk Factors Possibly Associated with Emerging Zoonotic Vaccinia Virus in a Farming Community, Colombia.

Authors:  Ashley Styczynski; Jillybeth Burgado; Diana Walteros; José Usme-Ciro; Katherine Laiton; Alejandra Pinilla Farias; Yoshinori Nakazawa; Christina Chapman; Whitni Davidson; Matthew Mauldin; Clint Morgan; Juan Martínez-Cerón; Edilson Patiña; Leidy Laura López Sepúlveda; Claudia Patricia Torres; Anyely Eliana Cruz Suarez; Gina Paez Olaya; Carlos Elkin Riveros; Diana Yaneth Cepeda; Leydi Acosta Lopez; Daniela Gomez Espinosa; Faiber Antonio Gutierrez Lozada; Yu Li; P S Satheshkumar; Mary Reynolds; Martha Gracia-Romero; Brett Petersen
Journal:  Emerg Infect Dis       Date:  2019-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.